Education :

• Ph.D., Biochemistry
• Institute of Biochemistry, National Chung Hsing University

Areas of Expertise :

• Pharmaceutical Dosage Form Development
• Strategic Planning for Innovative Drug R&D
• Prescription Drug Marketing & Medication-Use Analysis

Professional Summary :
    Dr. Robin Lin has extensive experience in pharmaceutical marketing and the biotechnology industry, previously serving at Mitsubishi Tanabe Pharma and innovative drug development companies. Dr. Lin has strong practical expertise in the prescription drug market and comprehensive capabilities in new drug development integration.
    Dr. Lin has led multiple preclinical development programs for innovative drug candidates and is highly skilled in integrating technology, regulatory strategies, and capital market considerations to ensure the effective execution of R&D projects. With deep insight into the biotechnology ecosystem and market trends, Dr. Lin continues to guide Ail Biotech in advancing 505(b)(2) innovative drug development and clinical applications.
    Currently, Dr. Lin is focused on expanding the company's pipeline into therapeutic areas with unmet medical needs, aiming to create greater value and more treatment options for patients.